The Latest Breaking News from COPD

A new report shows that four illnesses play a disproportionate role in making the North East the least healthy area of England

The U.S. Food and Drug Administration (FDA) has granted Fast Track designation to Relmada Therapeutics’ (NASDAQ:RLMD) lead asset REL-1017 as a monotherapy for the treatment major depressive disorder (MDD). Relmada shares traded in a range of $26.02 to $27.96 on a day volume of 173.79 thousand shares, closed regular trading…

Gainers Verona Pharma plc (NASDAQ: VRNA) shares jumped 83.6% to $12.70 after the company announced ensifentrine met its primary endpoint and secondary endpoints in the Phase 3 ENHANCE-2 trial for COPD. The company also reported Q2 earnings results.

More than 1.3 million people in the UK suffer from COPD

Researchers say 55% of COPD patients suffering two or more acute attacks a year earn under £20,000, with the poorest five times more likely to die from the condition

Those with asthma or COPD could find smoke from bonfires triggers their symptoms.

Monday marks the start of Love You Lungs week, a campaign to raise awareness of lung health. A lung condition can be permanent but there are treatments to slow down progression.

A neck patch that monitors respiratory sounds may help manage asthma and chronic obstructive pulmonary disease (COPD) by detecting symptom flareups in real time, without compromising patient privacy.

Exercise to help COPD hospital patients is being rolled out across Kyrgyzstan and to neighbouring countries

Charity Asthma and Lung UK is advising people with asthma and COPD to take action

Mum-of-two Amanda Aitken, 42, piled on the pounds during a heavily medicated battle with the respiratory condition COPD.